These interaction analyses showed lower whole-body insulin sensitivity during the OGTT (p = 0.04, Fig. 3A) and higher insulin resistance estimated from fasting glucose and insulin levels (HOMA2-IR; p = 0.01, Fig. 3B) for carrageenan with higher BMI. The gene discussed is INS; the disease is Insulin resistance.